144 related articles for article (PubMed ID: 31222103)
21. Dynamic role of the codon 72 p53 single-nucleotide polymorphism in mammary tumorigenesis in a humanized mouse model.
Gunaratna RT; Santos A; Luo L; Nagi C; Lambertz I; Spier M; Conti CJ; Fuchs-Young RS
Oncogene; 2019 May; 38(18):3535-3550. PubMed ID: 30651598
[TBL] [Abstract][Full Text] [Related]
22. Tiam1-deficiency impairs mammary tumor formation in MMTV-c-neu but not in MMTV-c-myc mice.
Strumane K; Rygiel T; van der Valk M; Collard JG
J Cancer Res Clin Oncol; 2009 Jan; 135(1):69-80. PubMed ID: 18592271
[TBL] [Abstract][Full Text] [Related]
23. Protein kinase Cδ is required for ErbB2-driven mammary gland tumorigenesis and negatively correlates with prognosis in human breast cancer.
Allen-Petersen BL; Carter CJ; Ohm AM; Reyland ME
Oncogene; 2014 Mar; 33(10):1306-15. PubMed ID: 23474764
[TBL] [Abstract][Full Text] [Related]
24. The insulin receptor content is increased in breast cancers initiated by three different oncogenes in transgenic mice.
Frittitta L; Cerrato A; Sacco MG; Weidner N; Goldfine ID; Vigneri R
Breast Cancer Res Treat; 1997 Sep; 45(2):141-7. PubMed ID: 9342439
[TBL] [Abstract][Full Text] [Related]
25. P190B RhoGAP has pro-tumorigenic functions during MMTV-Neu mammary tumorigenesis and metastasis.
McHenry PR; Sears JC; Herrick MP; Chang P; Heckman-Stoddard BM; Rybarczyk M; Chodosh LA; Gunther EJ; Hilsenbeck SG; Rosen JM; Vargo-Gogola T
Breast Cancer Res; 2010; 12(5):R73. PubMed ID: 20860838
[TBL] [Abstract][Full Text] [Related]
26. A temporal requirement for Hippo signaling in mammary gland differentiation, growth, and tumorigenesis.
Chen Q; Zhang N; Gray RS; Li H; Ewald AJ; Zahnow CA; Pan D
Genes Dev; 2014 Mar; 28(5):432-7. PubMed ID: 24589775
[TBL] [Abstract][Full Text] [Related]
27. Bax regulates c-Myc-induced mammary tumour apoptosis but not proliferation in MMTV-c-myc transgenic mice.
Jamerson MH; Johnson MD; Korsmeyer SJ; Furth PA; Dickson RB
Br J Cancer; 2004 Oct; 91(7):1372-9. PubMed ID: 15354213
[TBL] [Abstract][Full Text] [Related]
28. RARα1 control of mammary gland ductal morphogenesis and wnt1-tumorigenesis.
Cohn E; Ossowski L; Bertran S; Marzan C; Farias EF
Breast Cancer Res; 2010; 12(5):R79. PubMed ID: 20923554
[TBL] [Abstract][Full Text] [Related]
29. The oncogene HER2/neu (ERBB2) requires the hypoxia-inducible factor HIF-1 for mammary tumor growth and anoikis resistance.
Whelan KA; Schwab LP; Karakashev SV; Franchetti L; Johannes GJ; Seagroves TN; Reginato MJ
J Biol Chem; 2013 May; 288(22):15865-77. PubMed ID: 23585570
[TBL] [Abstract][Full Text] [Related]
30. Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis.
Li H; Gumbiner BM
Mamm Genome; 2016 Dec; 27(11-12):556-564. PubMed ID: 27601049
[TBL] [Abstract][Full Text] [Related]
31. PTEN deficiency in a luminal ErbB-2 mouse model results in dramatic acceleration of mammary tumorigenesis and metastasis.
Schade B; Rao T; Dourdin N; Lesurf R; Hallett M; Cardiff RD; Muller WJ
J Biol Chem; 2009 Jul; 284(28):19018-26. PubMed ID: 19435886
[TBL] [Abstract][Full Text] [Related]
32. Hormone-sensing cells require Wip1 for paracrine stimulation in normal and premalignant mammary epithelium.
Tarulli GA; De Silva D; Ho V; Kunasegaran K; Ghosh K; Tan BC; Bulavin DV; Pietersen AM
Breast Cancer Res; 2013 Jan; 15(1):R10. PubMed ID: 23369183
[TBL] [Abstract][Full Text] [Related]
33. The glucose transporter GLUT1 is required for ErbB2-induced mammary tumorigenesis.
Wellberg EA; Johnson S; Finlay-Schultz J; Lewis AS; Terrell KL; Sartorius CA; Abel ED; Muller WJ; Anderson SM
Breast Cancer Res; 2016 Dec; 18(1):131. PubMed ID: 27998284
[TBL] [Abstract][Full Text] [Related]
34. Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis.
Dong Y; Van Tine BA; Oyama T; Wang PI; Cheng EH; Hsieh JJ
Cell Res; 2014 Nov; 24(11):1354-66. PubMed ID: 25267403
[TBL] [Abstract][Full Text] [Related]
35. In vivo analysis of mammary and non-mammary tumorigenesis in MMTV-cyclin D1 transgenic mice deficient in p53.
Hosokawa Y; Papanikolaou A; Cardiff RD; Yoshimoto K; Bernstein M; Wang TC; Schmidt EV; Arnold A
Transgenic Res; 2001 Oct; 10(5):471-8. PubMed ID: 11708657
[TBL] [Abstract][Full Text] [Related]
36. Activated Akt1 accelerates MMTV-c-ErbB2 mammary tumourigenesis in mice without activation of ErbB3.
Young CD; Nolte EC; Lewis A; Serkova NJ; Anderson SM
Breast Cancer Res; 2008; 10(4):R70. PubMed ID: 18700973
[TBL] [Abstract][Full Text] [Related]
37. p63 is a prosurvival factor in the adult mammary gland during post-lactational involution, affecting PI-MECs and ErbB2 tumorigenesis.
Yallowitz AR; Alexandrova EM; Talos F; Xu S; Marchenko ND; Moll UM
Cell Death Differ; 2014 Apr; 21(4):645-54. PubMed ID: 24440910
[TBL] [Abstract][Full Text] [Related]
38. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
Bocchinfuso WP; Hively WP; Couse JF; Varmus HE; Korach KS
Cancer Res; 1999 Apr; 59(8):1869-76. PubMed ID: 10213494
[TBL] [Abstract][Full Text] [Related]
39. Use of the disulfiram/copper complex for breast cancer chemoprevention in MMTV-erbB2 transgenic mice.
Yang Y; Deng Q; Feng X; Sun J
Mol Med Rep; 2015 Jul; 12(1):746-52. PubMed ID: 25738885
[TBL] [Abstract][Full Text] [Related]
40. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
